Oct 02, 2019 / 05:50PM GMT
Jordan Abrams - Cantor Fitzgerald - Analyst
Good afternoon. My name is Jordan Abrams. I'm the tools and diagnostics analyst here at Cantor. We're delighted to have CareDx present next. CareDx is a molecular diagnostic company focused on the transplant testing space. Right now the Company's a leading position in cardiac transplant testing, and is towards the earlier days of kidney transplant testing.
Presenting for the Company is CEO, Peter Maag; and CFO, Michael Bell.
Peter Maag - CareDx, Inc. - CEO
Jordan, thank you so much. And thank you for Cantor to host us here at CareDx. We have a full day today. And so I was just joking with Jordan that this is probably the maximum that we can handle, just in terms of booking us back to back. So thank you very much for your interest.
These are our disclaimers; please see our website for additional information.
What we at CareDx do is we focus on transplantation. And on this page, maybe for those of you that have followed the Company for a long period of time, we talked a lot about
CareDx Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers